Panbela Therapeutics, Inc. (NASDAQ:PBLA) Q2 2024 Earnings Call Transcript August 13, 2024
Panbela Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.47, expectations were $-2.07.
Operator: Good afternoon, everyone, and welcome to the Panbela Therapeutics Second Quarter 2024 Earnings Call. At this time, all participants have been placed on a listen-only mode. And we will open the floor for your questions and comments after the presentation. It is now my pleasure to turn the...
